 |
[Alpha Biz=(Chicago) Reporter Kim Jisun] Celltrion Holdings has continued to buy shares in Celltrion this year.
According to the Financial Supervisory Service's electronic disclosure system on the 23rd, Celltrion Holdings will buy 25,000 shares of Celltrion on the same day and 31,000 shares on the 23rd today. The amount is 4.396 billion won on the 22nd and 5.453 billion won on the 23rd, totaling 9.849 billion won. As a result, Celltrion Holdings' stake in Celltrion rose slightly from 21.6% to 21.86%.
It is to continue its in-house purchase that has resumed for the first time in two years since 2021 when it started buying in the market to meet the Fair Trade Act requirements (maintain more than a 20% stake in listed subsidiaries). Celltrion Holdings started buying its subsidiaries Celltrion and Celltrion Healthcare at the end of last year. It bought 198,953 shares of Celltrion on 12 occasions and 201,230 shares of Celltrion Healthcare on nine occasions. Celltrion is worth 31.045 billion won and Celltrion Healthcare is worth 14.119 billion won. Since then, Celltrion Healthcare has been merged into Celltrion, and Celltrion Holdings' integrated Celltrion stake has become 21.6%.
Currently, the integrated Celltrion goal is to achieve sales of 12 trillion won by 2030. The pre-depreciation operating profit (EBITA) forecast is 1.7 trillion won this year, 3.5 trillion won in 2025 and more than 6 trillion won in 2026.
Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)
